The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $1,050,000.00 definitive contract to The Research Foundation For The State University Of New York (SUNY) to conduct a study on the systemic approach to predicting the excretion of antidepressants into breast milk. This contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) issued by the FDA seeking advanced research and development proposals to support...
This is a $584,639 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Husson University, doing business as Nescom, for a research project titled "PREDICTING THE TRANSFER OF BREAST CANCER RESISTANT PROTEIN (BCRP) SUBSTRATES INTO HUMAN MILK USING IN VITRO TO IN VIVO EXTRAPOLATION (IVIVE)." The contract, which has a completion date of September 27, 2023, does not have a set-aside designation. Nescom, a private non-profit educational institution, is...
The Research Foundation for the State University of New York (RF SUNY), a non-profit organization, was awarded a $794,505.55 federal contract (Contract ID: 75F40118C10188) by the Food and Drug Administration (FDA) to develop a physiologically-based model of the female reproductive tract, including components for vaginal and intrauterine drug delivery. The contract supports new approaches to improve product manufacturing and quality. This award was not set aside. RF SUNY will be the prime...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) in the amount of $149,999.00 to The Research Foundation for the State University of New York (SUNY), the prime contractor. The contract is for critical functions, with no set-aside designation, and has an ultimate completion date of May 25, 2018. The Research Foundation for SUNY is a non-profit organization that serves as the sponsored programs administrator for the SUNY system, managing...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $480,286.05 firm fixed price definitive contract to The Research Foundation For The State University Of New York (doing business as Sponsored Projects Services) to evaluate the use of longitudinal real-time (LRT) methods for post-market surveillance of adverse events. The Research Foundation For The State University Of New York is a non-profit organization that serves as the sponsored programs office for...
This is a $5,323,187.99 firm fixed price contract awarded by the U.S. Army Medical Command to The Research Foundation for the State University of New York (SUNY), a non-profit organization that serves as the sponsored programs administrator for the SUNY system. The contract has an ultimate completion date of April 13, 2020 and was not set aside for any specific business type. As the prime contractor, The Research Foundation for SUNY has provided a range of research, scientific support, and...
This is a $11,728,252.94 indefinite delivery contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Research Foundation for the State University of New York (RF SUNY) for Clinical Pharmacology Quality Assurance services. The contract has no set-aside designation. RF SUNY, a non-profit organization, is the prime contractor and has subcontracted with Frontier Science & Technology Research Foundation,...
This federal contract award, HHSN275200403394C, was issued by the National Institute of Child Health and Human Development, a civilian agency, to The Research Foundation for the State University of New York (RF SUNY) as the prime contractor. The $6,396,260.96 definitive contract is for research on the "Effect of Hormones on Oxidative Stress" and does not have a set-aside designation. RF SUNY is a non-profit organization that provides research administration and support services to...
This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...
This is a $1,050,310 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which has no set-aside designation, is for a project titled "CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP" with a period of performance ending on March 7, 2025. The contract was awarded under a Broad Agency...